Amplifon Stock Price, News & Analysis (OTCMKTS:AMFPF) $27.90 0.00 (0.00%) (As of 11/28/2023 ET) Add Compare Share Share Today's Range$27.90▼$27.9050-Day Range$27.90▼$31.2252-Week Range$19.11▼$35.88VolumeN/AAverage Volume48 shsMarket Capitalization$6.32 billionP/E Ratio34.88Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest About Amplifon Stock (OTCMKTS:AMFPF)Amplifon S.p.A. engages in the distribution of hearing solutions that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It is also involved in fitting of customized products. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy.Read More AMFPF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMFPF Stock News HeadlinesNovember 29, 2023 | finance.yahoo.comAmplifon, Hearing Care Experts, Expands Its Footprint in Alberta and Reaches More Than 130 Stores in CanadaOctober 30, 2023 | msn.comAmplifon lowers profit forecast on weak European market, shares dropNovember 29, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!October 30, 2023 | news.yahoo.comAmplifon lowers profit forecast on weak demand, global uncertaintyOctober 29, 2023 | markets.businessinsider.comWhat Wall Street expects from Amplifon Post Frazionamento's earningsAugust 22, 2023 | finance.yahoo.comAmplifon Australia Opens Its Headquarters in Central MelbourneJuly 27, 2023 | markets.businessinsider.comAmplifon Post Frazionamento earnings preview: what Wall Street is expectingMay 31, 2023 | benzinga.comAmplifon named to Newsweek's list of the Top 100 Global Most Loved Workplaces for 2023November 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comMay 2, 2023 | msn.comItalian hearing aid maker Amplifon expects higher 2023 earningsFebruary 19, 2023 | barrons.comAmplifon S.p.A.February 17, 2023 | seekingalpha.comSonova: Buy This Beneficiary Of An Aging PopulationJanuary 18, 2023 | finance.yahoo.comAmplifon Americas Recognized as a ‘Top Employer’ in the U.S.January 17, 2023 | wsj.comAmplifon Americas Recognized as a 'Top Employer' in the U.S.September 20, 2022 | seekingalpha.comCAH Cardinal Health, Inc.July 30, 2022 | seekingalpha.comAmplifon S.p.A. (AMFPF) CEO Enrico Vita on Q2 2022 Results - Earnings Call TranscriptMay 3, 2022 | seekingalpha.comAmplifon S.p.A. (AMFPF) CEO Enrico Vita on Q1 2022 Results - Earnings Call TranscriptMay 3, 2022 | uk.finance.yahoo.comItaly's Amplifon confirms 2022 guidanceMarch 2, 2022 | markets.businessinsider.comHere's what Wall Street expects from Amplifon Post Frazionamento's earnings reportFebruary 28, 2022 | tmcnet.comWorld Hearing Day 2022: Amplifon Joins "To Hear For Life, Listen With Care" Global WHO CampaignSeptember 13, 2021 | nasdaq.comAmplifon sees 'high single digit' growth in revenues in 2022 and 2023September 13, 2021 | nasdaq.comAmplifon sees 'high single digit' sales growth in 2022, 2023July 27, 2021 | markets.businessinsider.comAmplifon Post Frazionamento is about to announce its earnings — here's what Wall Street expectsJuly 12, 2021 | reuters.comItaly's Amplifon buys Australia's Bay AudioJuly 12, 2021 | nasdaq.comItalian hearing aid maker Amplifon buys Australia's Bay AudioJuly 6, 2021 | marketwatch.comAmplifon Forms JV With Chinese Hearing-Care RetailerJuly 6, 2021 | nasdaq.comItaly's Amplifon expands Chinese retail business with new JVSee More Headlines Receive AMFPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amplifon and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today11/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:AMFPF CUSIPN/A CIKN/A Webcorporate.amplifon.com Phone(390) 257-4721FaxN/AEmployees13,195Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.80 Trailing P/E Ratio34.88 Forward P/E RatioN/A P/E GrowthN/ANet Income$188.09 million Net Margins7.90% Pretax MarginN/A Return on Equity17.47% Return on Assets5.06% Debt Debt-to-Equity Ratio0.63 Current Ratio0.48 Quick Ratio0.42 Sales & Book Value Annual Sales$2.23 billion Price / Sales2.83 Cash Flow$1.97 per share Price / Cash Flow14.16 Book Value$4.84 per share Price / Book5.76Miscellaneous Outstanding Shares226,389,000Free FloatN/AMarket Cap$6.32 billion OptionableNot Optionable Beta0.57 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Enrico Vita (Age 54)CEO, MD, GM & Executive Director Comp: $4.56MMr. Gabriele Galli (Age 54)Executive of Financial Reporting & Corporate Accounting Information and CFO Mr. Andrea CiccoliniChief Information OfficerMs. Francesca RambaudiInvestor Relations DirectorMr. Salvatore RiccoChief Communication OfficerMr. Giuseppe VirondaChief Marketing OfficerMs. Francesca Morichini (Age 45)Chief HR Officer Mr. Riccardo Cattaneo (Age 60)Chief Regulatory Officer Mr. Federico BardelliChief Retail Excellence OfficerMr. Paolo LazzariniChief Strategy & Business Development OfficerMore ExecutivesKey CompetitorsSWEDISH ORPHAN/SOTCMKTS:SWTUYOrion OyjOTCMKTS:ORINYDiaSorinOTCMKTS:DSRLFHikma PharmaceuticalsOTCMKTS:HKMPFAspen PharmacareOTCMKTS:APNHYView All Competitors AMFPF Stock Analysis - Frequently Asked Questions Should I buy or sell Amplifon stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Amplifon in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMFPF shares. View AMFPF analyst ratings or view top-rated stocks. How have AMFPF shares performed in 2023? Amplifon's stock was trading at $25.00 at the beginning of the year. Since then, AMFPF shares have increased by 11.6% and is now trading at $27.90. View the best growth stocks for 2023 here. Are investors shorting Amplifon? Amplifon saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 2,441,900 shares, a decline of 17.9% from the October 15th total of 2,975,100 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days. View Amplifon's Short Interest. How do I buy shares of Amplifon? Shares of AMFPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:AMFPF) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplifon S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.